VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 367 filers reported holding VANECK VECTORS ETF TR in Q3 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,271,200 | -94.4% | 260,000 | -93.6% | 0.05% | -94.4% |
| Q2 2022 | $111,104,645 | -41.7% | 4,057,876 | -18.3% | 0.92% | -22.9% |
| Q1 2022 | $190,438,430 | +200.5% | 4,965,800 | +151.0% | 1.20% | +222.6% |
| Q4 2021 | $63,374,558 | -21.4% | 1,978,600 | -27.6% | 0.37% | -36.9% |
| Q3 2021 | $80,579,821 | -39.6% | 2,734,300 | -30.4% | 0.59% | -30.0% |
| Q2 2021 | $133,423,795 | +528.1% | 3,926,539 | +500.7% | 0.84% | +349.2% |
| Q1 2021 | $21,243,270 | -47.7% | 653,639 | -42.0% | 0.19% | -41.4% |
| Q4 2020 | $40,621,159 | +123.1% | 1,127,739 | +142.5% | 0.32% | +58.7% |
| Q3 2020 | $18,210,000 | -27.9% | 465,001 | -32.5% | 0.20% | -32.3% |
| Q2 2020 | $25,254,000 | -26.3% | 688,486 | -53.7% | 0.30% | -21.8% |
| Q1 2020 | $34,243,000 | -29.4% | 1,486,244 | -10.3% | 0.38% | +1.1% |
| Q4 2019 | $48,532,000 | +63.2% | 1,657,518 | +48.9% | 0.38% | +63.5% |
| Q3 2019 | $29,731,000 | -54.1% | 1,113,092 | -56.1% | 0.23% | -51.4% |
| Q2 2019 | $64,826,000 | +310.4% | 2,536,232 | +260.0% | 0.47% | +263.8% |
| Q1 2019 | $15,796,000 | -52.0% | 704,569 | -54.8% | 0.13% | -51.3% |
| Q4 2018 | $32,901,000 | -33.1% | 1,560,081 | -41.3% | 0.27% | -16.8% |
| Q3 2018 | $49,188,000 | +125.7% | 2,655,986 | +171.9% | 0.32% | +161.0% |
| Q2 2018 | $21,796,000 | +29.0% | 976,919 | +27.1% | 0.12% | +35.2% |
| Q1 2018 | $16,891,000 | -6.8% | 768,455 | -1.5% | 0.09% | +8.3% |
| Q4 2017 | $18,132,000 | +108.4% | 780,161 | +105.9% | 0.08% | +44.8% |
| Q3 2017 | $8,701,000 | -19.1% | 378,969 | -22.2% | 0.06% | -19.4% |
| Q2 2017 | $10,753,000 | +449.5% | 487,000 | +467.6% | 0.07% | +414.3% |
| Q1 2017 | $1,957,000 | -91.2% | 85,794 | -92.0% | 0.01% | -88.9% |
| Q4 2016 | $22,356,000 | +113.7% | 1,068,608 | +169.9% | 0.13% | +133.3% |
| Q3 2016 | $10,463,000 | +16.5% | 395,860 | +22.1% | 0.05% | +35.0% |
| Q2 2016 | $8,981,000 | – | 324,087 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |